Literature DB >> 12662360

Identification and characterization of peptide probes directed against PKCalpha conformations.

S S Ashraf1, E Anderson, K Duke, P T Hamilton, Z Fredericks.   

Abstract

Phage display is a powerful technology that allows identification of high affinity peptides that bind specifically to a given molecular target. Using a highly complex peptide display library, we have identified separate classes of peptides that bind to protein kinase C alpha (PKCalpha) only under activation conditions. Furthermore, peptide binding was specific to PKCalpha and not to any of the other closely related PKC isoforms. The conformational and isoform specificity of the peptide binding was demonstrated using surface plasmon resonance as well as time-resolved fluorescence assays. Kinase assays showed that these peptides were not direct substrates for PKC nor did they inhibit phosphorylation of PKC substrates. These peptides are most likely directed against protein-protein interaction sites on PKC. The data presented here offers another example of application of phage display technology to identify conformation-dependent peptide probes against therapeutically important drug targets. These peptides are ideally suited to be used as surrogate ligands to identify compounds that bind specifically to PKCalpha, as well as conformational probes to detect activated forms of PKCalpha.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12662360     DOI: 10.1034/j.1399-3011.2003.00056.x

Source DB:  PubMed          Journal:  J Pept Res        ISSN: 1397-002X


  2 in total

1.  The proline repeat domain of p53 binds directly to the transcriptional coactivator p300 and allosterically controls DNA-dependent acetylation of p53.

Authors:  David Dornan; Harumi Shimizu; Lindsay Burch; Amanda J Smith; Ted R Hupp
Journal:  Mol Cell Biol       Date:  2003-12       Impact factor: 4.272

2.  Structure of Galpha(i1) bound to a GDP-selective peptide provides insight into guanine nucleotide exchange.

Authors:  Christopher A Johnston; Francis S Willard; Mark R Jezyk; Zoey Fredericks; Erik T Bodor; Miller B Jones; Rainer Blaesius; Val J Watts; T Kendall Harden; John Sondek; J Kevin Ramer; David P Siderovski
Journal:  Structure       Date:  2005-07       Impact factor: 5.006

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.